Gilead Sciences, Inc. (NASDAQ:GILD) announced that it has entered into an agreement with Compugen Ltd (NASDAQ:CGEN) to exclusively license Compugens...…
US biopharmaceutical giant Gilead Sciences Inc. (Nasdaq: GILD) today announced an agreement with Israeli clinical-stage cancer immunotherapy company Compugen…